GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 24 filers reported holding GALMED PHARMACEUTICALS LTD in Q4 2021. The put-call ratio across all filers is 9.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $56 | -25.3% | 131,628 | -11.8% | 0.00% | – |
| Q4 2022 | $75 | -99.5% | 149,217 | +218.4% | 0.00% | – |
| Q3 2022 | $15,000 | -57.1% | 46,866 | -7.6% | 0.00% | – |
| Q2 2022 | $35,000 | +105.9% | 50,748 | +372.3% | 0.00% | – |
| Q1 2022 | $17,000 | -82.5% | 10,745 | -79.8% | 0.00% | – |
| Q4 2021 | $97,000 | +169.4% | 53,239 | +308.4% | 0.00% | – |
| Q3 2021 | $36,000 | -56.1% | 13,036 | -44.9% | 0.00% | – |
| Q1 2020 | $82,000 | -5.7% | 23,658 | +57.7% | 0.00% | – |
| Q4 2019 | $87,000 | -38.3% | 15,000 | -27.6% | 0.00% | – |
| Q4 2018 | $141,000 | -96.9% | 20,706 | -93.7% | 0.00% | -100.0% |
| Q3 2018 | $4,483,000 | +19.5% | 330,103 | +4.7% | 0.01% | 0.0% |
| Q2 2018 | $3,753,000 | +3892.6% | 315,356 | +1768.2% | 0.01% | – |
| Q1 2018 | $94,000 | – | 16,880 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,347,755 | $574,818 | 0.02% |
| Virtu Financial LLC | 31,633 | $13 | 0.00% |
| Western Wealth Management, LLC | 29,537 | $12,597 | 0.00% |
| Belpointe Asset Management LLC | 14,050 | $5,992 | 0.00% |
| TSFG, LLC | 3,000 | $1 | 0.00% |
| ZRC WEALTH MANAGEMENT, LLC | 100 | $43 | 0.00% |
| Allworth Financial LP | 250 | $107 | 0.00% |
| JANE STREET GROUP, LLC | 13,189 | $5,625 | 0.00% |
| RAYMOND JAMES & ASSOCIATES | 138,040 | $58,874 | 0.00% |
| BOURGEON CAPITAL MANAGEMENT LLC | 500 | $214 | 0.00% |